Gruber A, Ungersböck K, Reinprecht A, Czech T, Gross C, Bednar M, Richling B
Department of Neurosurgery, University of Vienna Medical School, Austria.
Neurosurgery. 1998 Feb;42(2):258-67; discussion 267-8. doi: 10.1097/00006123-199802000-00032.
To document the influence of the treatment modality (early surgery versus early endovascular treatment) on measures of cerebral vasospasm in a nonrandomized series of 156 patients treated within 72 hours of aneurysmal subarachnoid hemorrhage.
The following parameters were prospectively collected in a computerized data base and retrospectively analyzed for association with vasospasm-related ischemic infarctions: 1) Hunt and Hess (H&H) grade, 2) Fisher grade, 3) highest mean cerebral blood flow velocity (CBFVMAX) and maximum percent change in mean CBFV (%deltaCBFV) as recorded by transcranial Doppler ultrasound, 4) incidence of repeat subarachnoid hemorrhage, 5) incidence of delayed ischemic neurological deficits, 6) incidence of delayed ischemic infarctions, and 7) Glasgow Outcome Scale score.
Forty-one patients (26.3%) suffered ischemic infarctions. The ischemic infarction rate was correlated with higher H&H grade (P = 0.002), higher Fisher grade (P = 0.05), higher CBFVMAX (P < 0.001) and %deltaCBFV (P = 0.01), occurrence of repeat subarachnoid hemorrhage, occurrence of delayed ischemic neurological deficits, and endovascular treatment (P = 0.02).
The infarction rate was higher with endovascular treatment versus surgery (37.7 versus 21.6%), as a result of a skewed Fisher Grade 4 infarction pattern in the endovascular treatment group versus the surgery treatment group (66.7 versus 24.5%). We suspect that unremoved subarachnoid/intracerebral clots contributed to the higher infarction rate with endovascular treatment. When patients with Fisher Grade 4 and H&H Grade V were excluded from analysis, the difference in infarct incidence between the treatment groups no longer reached statistical significance (Fisher Grades 1-3, P = 0.49; H&H Grades I-IV, P = 0.96).
在156例动脉瘤性蛛网膜下腔出血后72小时内接受治疗的非随机系列患者中,记录治疗方式(早期手术与早期血管内治疗)对脑血管痉挛测量指标的影响。
以下参数前瞻性收集于计算机数据库中,并进行回顾性分析以确定其与血管痉挛相关缺血性梗死的关联:1)Hunt和Hess(H&H)分级;2)Fisher分级;3)经颅多普勒超声记录的最高平均脑血流速度(CBFVMAX)和平均CBFV的最大变化百分比(%deltaCBFV);4)再发性蛛网膜下腔出血的发生率;5)延迟性缺血性神经功能缺损的发生率;6)延迟性缺血性梗死的发生率;7)格拉斯哥预后量表评分。
41例患者(26.3%)发生缺血性梗死。缺血性梗死率与较高的H&H分级(P = 0.002)、较高的Fisher分级(P = 0.05)、较高的CBFVMAX(P < 0.001)和%deltaCBFV(P = 0.01)、再发性蛛网膜下腔出血的发生、延迟性缺血性神经功能缺损的发生以及血管内治疗(P = 0.02)相关。
血管内治疗组的梗死率高于手术组(37.7%对21.6%),这是由于血管内治疗组与手术治疗组的Fisher 4级梗死模式存在偏差(66.7%对24.5%)。我们怀疑未清除的蛛网膜下腔/脑内血凝块导致了血管内治疗时较高的梗死率。当将Fisher 4级和H&H V级患者排除在分析之外时,治疗组之间梗死发生率的差异不再具有统计学意义(Fisher 1 - 3级,P = 0.49;H&H I - IV级,P = 0.96)。